抗疟疾药物耐药性的新变化
José Cubillán-Marín1, Tim W Gilberger1
1Centre for Structural Systems Biology, 22607 Hamburg, Germany; Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany; University of Hamburg, 20146 Hamburg, Germany.
Cell chemical biology
|October 17, 2025
概括
疟疾寄生虫对Halofuginone的耐药性源于氨基酸载体PfApiAT2的突变,而不是其预期的目标. 这一发现揭示了氨基酸运输作为抗疟疾药物开发的新目标.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
背景情况:
- 哈洛富基是一种针对prolyl-tRNA合成酶的抗疟疾药物候选剂.
- 耐药性是疟疾治疗的一个主要挑战,需要新的治疗策略.
研究的目的:
- 为了研究疟疾寄生虫对Halofuginone耐药性的机制.
- 为了确定疟疾寄生虫中halofuginone耐药性的遗传基础.
主要方法:
- 对抗疟疾寄生虫菌株的遗传分析.
- 在PfApiAT2.2中发现突变的功能性特征.
- 在修饰的寄生虫系中评估halofuginone易感性.
主要成果:
- 氨基酸载体PfApiAT2的突变,赋予了对halofuginone的耐药性.
- 耐药性是由PfApiAT2的改变介导的,独立于药物的标,prolyl-tRNA合成酶.
- 这种抵抗机制是快速的,并且特定于氨基酸运输.
结论:
- 疟疾寄生虫对Halofuginone的耐药性主要是由PfApiAT2载体的突变驱动的.
- 准氨基酸运输通路为抗疟疾药物发现提供了一个有希望的新战略.
- 了解耐药机制对于开发可持续的疟疾控制干预措施至关重要.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:30Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K